INNOVACE TABLETS
- Name:
INNOVACE TABLETS
- Company:
MSD Ireland (Human Health) Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 27/11/19

Click on this link to Download PDF directly
MSD Ireland (Human Health) Limited
 Limited.gif)
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 27 November 2019 SmPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Deletion of the 60 tablet pack size for Innovace 5 mg Tablets
Updated on 27 November 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
- Deletion of a pack size
Updated on 20 June 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to warnings or special precautions for use
- Change to drug interactions
Updated on 19 June 2019 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
New text regarding concomitant use of other drugs that may increase serum potassium levels (e.g. trimethoprim/sulfamethoxazole)
Updated on 28 March 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to warnings or special precautions for use
- Change of contraindications
- Change to drug interactions
Updated on 28 March 2019 SmPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated regarding drug interaction between ACE-inhibitor and neprilysin (NEP) inhibitor resulting in an increased risk of angioedema
Updated on 29 August 2018 SmPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Change to section 6.5 Nature and contents of container e.g. Innovace 5 mg tablet has a new pack size of 56 tablets
Updated on 15 August 2018 PIL
Reasons for updating
- Change to section 4 - how to report a side effect
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 15 March 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 15 March 2018 PIL
Reasons for updating
- Change to section 3 - how to take/use
- Change to section 6 - date of revision
Updated on 13 May 2016 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to drug interactions
- Change to date of revision
Updated on 10 May 2016 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 10 May 2016 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Change to Section 4.4 - Special warnings and precautions for use
Change to Section 4.5 - Interactions with other medicinal products and other forms of interaction
Change to Section 10 - Date of revision of the textReasons for submission: Type II036; Angiodema and ACE inhibitor and mTOR update
Updated on 10 February 2015 SmPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Change to Section 4.3 - Contraindications
Change to Section 4.4 - Special warnings and precautions for use
Change to Section 4.5 - Interactions with other medicinal products and other forms of interaction
Change to Section 4.8 - Undesirable effects
Change to Section 5.1 - Pharmacodynamic properties
Change to Section 10 - Date of revision of the text
Updated on 9 February 2015 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
- Change to side-effects
- Change to drug interactions
- Change to date of revision
Updated on 26 June 2014 SmPC
Reasons for updating
- Change to section 9 - Date of renewal of authorisation
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 21 May 2014 PIL
Reasons for updating
- Change to MA holder contact details
Updated on 25 April 2014 SmPC
Reasons for updating
- Change to section 8 - MA number
- Change to section 7 - Marketing authorisation holder
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Which SPC sections have changed: Sections 7 & 8 Change information: Change to the MAH name and address and new PA numbers.
Updated on 13 March 2014 PIL
Reasons for updating
- Change of contraindications
- Change to information about pregnancy or lactation
Updated on 29 January 2014 SmPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.3, 4.4, 4.5, 4.6, 4.8
Detailed SPC change information: Added a warning that the combination of aliskiren-containing medicines and ACE inhibitors.
Updated on 24 September 2012 PIL
Reasons for updating
- Change to information about pregnancy or lactation
Updated on 12 June 2012 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.4, 4.5, 4.6, 5.2, 10 - Added warnings on drug interactions; updated text on pregnancy and lactation
Updated on 11 February 2011 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 9 February 2011 SmPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update to section 4.5 - drug interactions (completion of II19) - Warnings on drug interactions
Updated on 8 June 2010 SmPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Update to section 6.5 and 10 - Harmonised pack sizes
Updated on 7 June 2010 PIL
Reasons for updating
- Change to further information section
Updated on 6 April 2010 SmPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.8 - Undesirable effects
- Change to section 6.1 - List of excipients
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Renewal completion - Sections 2, 3, 4.8, 6.1, 6.4, 6.5
Detailed SPC change information: Composition, Storage conditions
Updated on 29 March 2010 PIL
Reasons for updating
- Correction of spelling/typing errors
Updated on 17 November 2009 SmPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 6.1 - List of excipients
- Change to section 6.3 - Shelf life
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on completion of variation to reduce shelf-life II/16
Sections: 3, 6.1, 6.3:
Shelf-life reduced to 2 years.
Pharmaceutical form description - minor editorial changes.
Excipients names amended.
Updated on 3 September 2009 SmPC
Reasons for updating
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
No change to any sections. (Section 4.6 duplicated and incorrectly placed before Sec. 4.5)
Deletion of Section 4.6 inserted incorrectly before Section 4.5
Updated on 10 March 2009 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
- Change to section 5.2 - Pharmacokinetic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
The changes are as a result of a variation to amend the following sections of the SmPC; 4.4 (Special warnings and special precautions for use), 4.6 (Pregnancy and lactation) and 5.2 (Pharmacokinetic properties) in response to the recommendation by the Pharmacovigilance Working Party regarding ACE inhibitors and lactation.
Updated on 6 February 2009 SmPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
The variation to include the term "syndrome of inappropriate antidiuretic hormone secretion" (SIADH) has been added to section 4.8 of the SmPC.
Updated on 3 September 2008 PIL
Reasons for updating
- Change to information about pregnancy or lactation
Updated on 27 August 2008 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.6 - Pregnancy and lactation
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
changed due to a variation to update pregnancy warning, sections 4.4 and 4.6 updated
Updated on 7 February 2008 PIL
Reasons for updating
- Change to information about pregnancy or lactation
- Change to drug interactions
- Change to side-effects
Updated on 23 August 2007 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
This update is due to changes in sections 4.4 and 4.5
Updated on 12 May 2006 PIL
Reasons for updating
- Change to warnings or special precautions for use
Updated on 27 March 2006 SmPC
Reasons for updating
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 16 January 2006 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 16 November 2004 SmPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 16 November 2004 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 9 August 2004 SmPC
Reasons for updating
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 21 February 2004 SmPC
Reasons for updating
- Change to joint SPC covering all presentations
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 19 June 2003 SmPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)